TRIFERIC

Drug Rockwell Medical, Inc.
Total Payments
$903,094
Transactions
340
Doctors
129
Companies
1

Payment Trends by Year

Year Amount Transactions Doctors
2020 $637,845 201 81
2019 $265,249 139 55

Payments by Nature

Nature of Payment Amount Transactions Share
Unspecified $451,420 36 50.0%
Consulting Fee $427,895 144 47.4%
Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program $13,468 4 1.5%
Travel and Lodging $7,356 27 0.8%
Food and Beverage $2,705 110 0.3%
Education $250.80 19 0.0%

Payments by Type

General
$451,674
304 transactions
Research
$451,420
36 transactions

Research Studies & Clinical Trials

Study Name Sponsor Amount Doctors
RMFPC 26 Rockwell Medical, Inc. $233,380 0
RMFPC 24 Rockwell Medical, Inc. $133,568 0
RMFPC-25 Rockwell Medical, Inc. $29,512 0
Heparin Rockwell Medical, Inc. $22,927 1
Heparin Study Rockwell Medical, Inc. $19,737 1
RM Heparin Study Rockwell Medical, Inc. $6,317 1
Triferic Pediatric Trial Rockwell Medical, Inc. $4,825 0
RMC-26 Rockwell Medical, Inc. $1,155 0

Top Doctors Receiving Payments for TRIFERIC — Page 6

Doctor Specialty Location Total Records
, MD Nephrology Lawrenceville, GA $12.38 1
, M.D Internal Medicine Indianapolis, IN $12.12 1
Samer Diab Agha Fort Lauderdale, FL $11.98 1
, M.D., M.P.H Nephrology Los Angeles, CA $11.94 1
, M.D Nephrology Mineola, NY $11.30 1

About TRIFERIC

TRIFERIC is a drug associated with $903,094 in payments to 129 healthcare providers, recorded across 340 transactions in the CMS Open Payments database. The primary manufacturer is Rockwell Medical, Inc..

Payment data is available from 2019 to 2020. In 2020, $637,845 was paid across 201 transactions to 81 doctors.

The most common payment nature for TRIFERIC is "Unspecified" ($451,420, 50.0% of total).

TRIFERIC is associated with 8 research studies, including "RMFPC 26" ($233,380).